{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:56:50Z","timestamp":1792587410569,"version":"4.5.0"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejmech.2021.113445","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T21:06:24Z","timestamp":1618952784000},"page":"113445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Fused-azepinones: Emerging scaffolds of medicinal importance"],"prefix":"10.1016","volume":"220","author":[{"given":"Ravikumar","family":"Akunuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasa","family":"Vadakattu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmitha","family":"Bujji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Veerareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9813-8694","authenticated-orcid":false,"given":"Y.V.","family":"Madhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Nanduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113445_bib1","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.3390\/molecules16119665","article-title":"A\u00a0journey under the Sea: the quest for marine anti-cancer alkaloids","volume":"16","author":"Tohme","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113445_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2041-1480-5-39","article-title":"The Porifera Ontology (PORO): enhancing sponge systematics with an anatomy ontology","volume":"5","author":"Thacker","year":"2014","journal-title":"J.\u00a0Biomed. Semant."},{"key":"10.1016\/j.ejmech.2021.113445_bib3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4319\/lo.2011.56.5.1577","article-title":"Complex interactions between marine sponges and their symbiotic microbial communities","volume":"56","author":"Freeman","year":"2011","journal-title":"Limnol. Oceanogr."},{"key":"10.1016\/j.ejmech.2021.113445_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jembe.2011.07.024","article-title":"Connectivity and stability of mesophotic coral reefs","volume":"408","author":"Slattery","year":"2011","journal-title":"J.\u00a0Exp. Mar. Biol. Ecol."},{"key":"10.1016\/j.ejmech.2021.113445_bib5","first-page":"535","article-title":"Sponges: an essential component of Caribbean coral reefs","volume":"69","author":"Diaz","year":"2001","journal-title":"Bull. Mar. Sci."},{"key":"10.1016\/j.ejmech.2021.113445_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1515\/znc-2009-1-223","article-title":"Nucleosides from the marine sponge Haliclona sp","volume":"64","author":"Wang","year":"2009","journal-title":"Z.\u00a0Naturforsch. C J. Biosci."},{"key":"10.1016\/j.ejmech.2021.113445_bib7","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.3390\/md12125817","article-title":"Marine nucleosides: structure, bioactivity, synthesis and biosynthesis","volume":"12","author":"Huang","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2021.113445_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/md8020313","article-title":"Bioactive sesterterpenes and triterpenes from marine sponges: occurrence and pharmacological significance","volume":"8","author":"Ebada","year":"2010","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2021.113445_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0305-1978(03)00143-1","article-title":"Sterols from six marine sponges","volume":"32","author":"Santalova","year":"2004","journal-title":"Biochem. Systemat. Ecol."},{"key":"10.1016\/j.ejmech.2021.113445_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bse.2013.03.022","article-title":"Sterols from sponges of Anavilhanas","volume":"49","author":"de Barros","year":"2013","journal-title":"Biochem. Systemat. Ecol."},{"key":"10.1016\/j.ejmech.2021.113445_bib11","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1006\/bbrc.2001.4890","article-title":"Isolation and evaluation of nonsiderophore cyclic peptides from marine sponges","volume":"283","author":"Guan","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113445_bib12","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1021\/np5006778","article-title":"Reniochalistatins A\u2013E, cyclic peptides from the marine sponge Reniochalina stalagmitis","volume":"77","author":"Zhan","year":"2014","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113445_bib13","series-title":"Handbook of Anticancer Drugs from Marine Origin","first-page":"113","article-title":"Cytotoxic cyclic peptides from the marine sponges","author":"Wakimoto","year":"2015"},{"key":"10.1016\/j.ejmech.2021.113445_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1568026613666131216110001","article-title":"Marine bromopyrrole alkaloids: synthesis and diverse medicinal applications","volume":"14","author":"Rane","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib15","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1021\/np300231f","article-title":"Palau\u2019amine and related oroidin alkaloids dibromophakellin and dibromophakellstatin inhibit the human 20S proteasome","volume":"75","author":"Lansdell","year":"2012","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113445_bib16","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s11179-006-0015-3","article-title":"Fatty acids and other lipids of marine sponges","volume":"31","author":"Rod\u2019kina","year":"2005","journal-title":"Russ. J. Mar. Biol."},{"key":"10.1016\/j.ejmech.2021.113445_bib17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/BF02533980","article-title":"Isoprenoid fatty acids from marine sponges. Are sponges selective?","volume":"22","author":"Nm","year":"1987","journal-title":"Lipids"},{"key":"10.1016\/j.ejmech.2021.113445_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3998\/ark.5550190.p008.948","article-title":"New cytotoxic cyclic peroxide acids from Plakortis sp. marine sponge","author":"Hoye","year":"2015","journal-title":"ARKIVOC"},{"key":"10.1016\/j.ejmech.2021.113445_bib19","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/np0200414","article-title":"New bioactive peroxides from marine sponges of the family plakiniidae","volume":"65","author":"Chen","year":"2002","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113445_bib20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/np50108a023","article-title":"Amino acid derivatives from the marine sponge jaspis digonoxea","volume":"57","author":"Rudi","year":"1994","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113445_bib21","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1021\/jo00075a029","article-title":"New polychlorinated amino acid derivatives from the marine sponge Dysidea herbacea","volume":"58","author":"Unson","year":"1993","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib22","first-page":"12","article-title":"Pharmacologically important natural products from marine sponges","volume":"4","author":"Joseph","year":"2011","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113445_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030580","article-title":"Trends in the discovery of new marine natural products from invertebrates over the last two decades \u2013 where and what are we bioprospecting?","volume":"7","author":"Leal","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113445_bib24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0040-4039(00)86943-9","article-title":"Isolation and X-ray crystal structure of a novel bromo-compound from two marine sponges","volume":"23","author":"Cimino","year":"1982","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113445_bib25","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1248\/cpb.31.2321","article-title":"Marine natural products. XII. On the chemical constituents of the Okinawan marine sponge Hymeniacidon aldis","volume":"31","author":"Kitagawa","year":"1983","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2021.113445_bib26","unstructured":"File:Axinella Verrucosa - Carantec.jpg - Wikimedia Commons."},{"key":"10.1016\/j.ejmech.2021.113445_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0040-4039(94)02222-W","article-title":"Total syntheses of hymenialdisine and debromohymenialdisine: stereospecific construction of the 2-amino-4-oxo-2-imidazolin-5(Z)-disubstituted y ylidene ring system","volume":"36","author":"Annoura","year":"1995","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113445_bib28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1021\/jo991277o","article-title":"A\u00a0practical synthesis of (Z)-debromohymenialdisine","volume":"65","author":"Barrios Sosa","year":"2000","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib29","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1021\/ol052266m","article-title":"A\u00a0new glycociamidine ring precursor: syntheses of (Z)-hymenialdisine, (Z)-2-debromohymenialdisine, and (\u00b1)-endo-2-debromohymenialdisine","volume":"7","author":"Papeo","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2021.113445_bib30","doi-asserted-by":"crossref","first-page":"9263","DOI":"10.1016\/j.tetlet.2003.10.074","article-title":"An expeditious multigram preparation of the marine protein kinase inhibitor debromohymenialdisine","volume":"44","author":"Portevin","year":"2003","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113445_bib31","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.tetlet.2014.10.022","article-title":"A\u00a0concise total synthesis of hymenialdisine","volume":"56","author":"Saleem","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113445_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-5521(00)00063-6","article-title":"Inhibition of cyclin-dependent kinases, GSK-3\u03b2 and CK1 by hymenialdisine, a marine sponge constituent","volume":"7","author":"Meijer","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113445_bib33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1021\/jm0102856","article-title":"Aldisine alkaloids from the philippine sponge Stylissa massa are potent inhibitors of mitogen-activated protein kinase kinase-1 (MEK-1)","volume":"45","author":"Tasdemir","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib34","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1016\/j.bmcl.2004.05.079","article-title":"Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine","volume":"14","author":"Sharma","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113445_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.chembiol.2004.01.015","article-title":"Synthesis and target identification of hymenialdisine analogs","volume":"11","author":"Wan","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113445_bib36","doi-asserted-by":"crossref","first-page":"10176","DOI":"10.1016\/j.tet.2012.09.097","article-title":"New bioactive alkaloids from the marine sponge Stylissa sp","volume":"68","author":"Fouad","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113445_bib37","first-page":"2327","article-title":"Activation of interleukin-6 gene expression through the NF-kappa B transcription factor","volume":"10","author":"Libermann","year":"1990","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113445_bib38","doi-asserted-by":"crossref","first-page":"21128","DOI":"10.1016\/S0021-9258(17)45336-1","article-title":"Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines","volume":"265","author":"Mukaida","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib39","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/1523-1747.ep12606225","article-title":"Transcriptional regulation of intercellular adhesion molecule-1: PMA-induction is mediated by NF\u03baB","volume":"104","author":"M\u00fcller","year":"1995","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ejmech.2021.113445_bib40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0022-3565(24)36795-3","article-title":"The natural product hymenialdisine inhibits interleukin-8 production in U937 cells by inhibition of nuclear factor-\u03bab","volume":"282","author":"Breton","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113445_bib41","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0022-3565(24)37100-9","article-title":"Inhibition of NF\u03baB-mediated interleukin-1\u03b2-stimulated prostaglandin E2 formation by the marine natural product hymenialdisine","volume":"283","author":"Roshak","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113445_bib42","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0022-3565(24)34938-9","article-title":"Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage\/chondrocyte cultures by the natural product, hymenialdisine","volume":"290","author":"Badger","year":"1999","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113445_bib43","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1021\/jm040013d","article-title":"Inhibition of cytokine production by hymenialdisine derivatives","volume":"47","author":"Sharma","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib44","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/jbmr.4025","article-title":"Hymenialdisine: a marine natural product that acts on both osteoblasts and osteoclasts and prevents estrogen-dependent bone loss in mice","volume":"35","author":"Wang","year":"2020","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.ejmech.2021.113445_bib45","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1128\/AAC.00515-10","article-title":"EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitors","volume":"54","author":"Kremb","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113445_bib46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/md14020028","article-title":"Alkaloids from the sponge Stylissa carteri present prospective scaffolds for the inhibition of human immunodeficiency virus 1 (HIV-1)","volume":"14","author":"O\u2019Rourke","year":"2016","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2021.113445_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.ne.11.030188.000333","article-title":"Microtubule-associated proteins: their potential role in determining neuronal morphology","volume":"11","author":"Matus","year":"1988","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113445_bib48","first-page":"177","article-title":"Uber eine eigenartige Erkrankung der Hirnrinde","volume":"18","author":"Alzheimer","year":"1907","journal-title":"Zentralbl. Nervenh. Psych."},{"key":"10.1016\/j.ejmech.2021.113445_bib49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An English translation of alzheimer\u2019s 1907 paper, ?Uber eine eigenartige erkankung der hirnrinde?","volume":"8","author":"Stelzmann","year":"1995","journal-title":"Clin. Anat."},{"key":"10.1016\/j.ejmech.2021.113445_bib50","first-page":"595","article-title":"The role of tau kinases in Alzheimer\u2019s disease","volume":"13","author":"Dolan","year":"2010","journal-title":"Curr. Opin. Drug Discov. Dev"},{"key":"10.1016\/j.ejmech.2021.113445_bib51","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1073\/pnas.95.16.9637","article-title":"Presenilin 1 associates with glycogen synthase kinase-3\u03b2 and its substrate tau","volume":"95","author":"Takashima","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113445_bib52","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0962-8924(98)01363-4","article-title":"The cell biology of \u03b2-amyloid precursor protein and presenilin in Alzheimer\u2019s disease","volume":"8","author":"Selkoe","year":"1998","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113445_bib53","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bbadis.2013.12.011","article-title":"Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases","volume":"1842","author":"Gan","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2021.113445_bib54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/cn500258c","article-title":"Bromoalkaloids protect primary cortical neurons from induced oxidative stress","volume":"6","author":"Leir\u00f3s","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113445_bib55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ibiod.2013.08.014","article-title":"Antifouling activities of hymenialdisine and debromohymenialdisine from the sponge Axinella sp","volume":"85","author":"Feng","year":"2013","journal-title":"Int. Biodeterior. Biodegrad."},{"key":"10.1016\/j.ejmech.2021.113445_bib56","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/md7040705","article-title":"A\u00a0submarine journey: the pyrrole-imidazole alkaloids","volume":"7","author":"Forte","year":"2009","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2021.113445_bib57","first-page":"1","article-title":"The alkaloids from Indonesian marine sponges","volume":"2","author":"Yunovilsa Putra","year":"2014","journal-title":"Oceanography"},{"key":"10.1016\/j.ejmech.2021.113445_bib58","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1039\/c29710001129","article-title":"New bromo-pyrrole derivatives from the sponge Agelas oroides","author":"Forenza","year":"1971","journal-title":"J.\u00a0Chem. Soc. D"},{"key":"10.1016\/j.ejmech.2021.113445_bib59","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/np50074a051","article-title":"The structure of Clathrodin, a novel alkaloid isolated from the caribbean Sea Sponge agelas clathrodes","volume":"54","author":"Morales","year":"1991","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113445_bib60","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1016\/0040-4039(96)00629-6","article-title":"Dispacamides, anti-histamine alkaloids from Caribbean Agelas sponges","volume":"37","author":"Cafieri","year":"1996","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113445_bib61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1021\/np50037a008","article-title":"Marine natural products: pyrrololactams from several sponges","volume":"48","author":"Schmitz","year":"1985","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113445_bib62","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1039\/c39800000435","article-title":"Characterization of a yellow compound isolated from the marine sponge Phakellia flabellata","author":"Sharma","year":"1980","journal-title":"J.\u00a0Chem. Soc., Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113445_bib63","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/BF01940735","article-title":"Hymenin, a novel \u03b1-adrenoceptor blocking agent from the Okinawan marine sponge Hymeniacidon sp","volume":"42","author":"Kobayashi","year":"1986","journal-title":"Experientia"},{"key":"10.1016\/j.ejmech.2021.113445_bib64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1021\/np980315g","article-title":"New alkaloids from the indopacific sponge Stylissa carteri","volume":"62","author":"Eder","year":"1999","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113445_bib65","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1016\/S0040-4020(01)91443-7","article-title":"Invertebres marins du lagon neo-caledonien-V Isolement et identification des metabolites d\u2019une nouvelle es","volume":"41","author":"de Nanteuil","year":"1985","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113445_bib66","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1021\/jo00221a041","article-title":"Stevensine, a novel alkaloid of an unidentified marine sponge","volume":"50","author":"Albizati","year":"1985","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib67","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1023\/A:1020811810223","article-title":"Chemical defense of the Caribbean reef sponge Axinella corrugata against predatory fishes","volume":"25","author":"Wilson","year":"1999","journal-title":"J.\u00a0Chem. Ecol."},{"key":"10.1016\/j.ejmech.2021.113445_bib68","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1139\/v90-250","article-title":"Antineoplastic agents. 168. Isolation and structure of axinohydantoin","volume":"68","author":"Pettit","year":"1990","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib69","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/jlac.1995199504105","article-title":"The isolation and structure elucidation of debromoaxinohydantoin","author":"Groszek","year":"1995","journal-title":"Lieb. Ann."},{"key":"10.1016\/j.ejmech.2021.113445_bib70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/10575639708048315","article-title":"Z-axinohydantoin and debromo-Z-axinohydantoin from the sponge Stylotella aurantium: inhibitors of protein kinase C","volume":"9","author":"Patil","year":"1997","journal-title":"Nat. Prod. Lett."},{"key":"10.1016\/j.ejmech.2021.113445_bib71","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1021\/np970565h","article-title":"New bromopyrrole alkaloids from Hymeniacidon sponge","volume":"61","author":"Inaba","year":"1998","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113445_bib72","first-page":"9","article-title":"Studies on the chemical constituents of the sponge Phakellia fusca Thiele","volume":"20","author":"Wenlin","year":"2001","journal-title":"Zhongguo Hai Yang Yao Wu"},{"key":"10.1016\/j.ejmech.2021.113445_bib73","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1016\/j.bmcl.2013.04.066","article-title":"Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor","volume":"23","author":"Yamaguchi","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113445_bib74","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/ol034950b","article-title":"Latonduines A and B, new alkaloids isolated from the marine sponge Stylissa carteri: structure elucidation, synthesis, and biogenetic implications","volume":"5","author":"Linington","year":"2003","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2021.113445_bib75","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.chembiol.2012.08.014","article-title":"Correction of F508del-CFTR trafficking by the sponge alkaloid latonduine is modulated by interaction with PARP","volume":"19","author":"Carlile","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113445_bib76","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1039\/C4OB00091A","article-title":"Callyspongisines A\u2013D: bromopyrrole alkaloids from an Australian marine sponge, Callyspongia sp","volume":"12","author":"Plisson","year":"2014","journal-title":"Org. Biomol. Chem."},{"issue":"Suppl 2","key":"10.1016\/j.ejmech.2021.113445_bib77","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1007\/BF01778293","article-title":"Effects of a protein kinase C inhibitor (PKCI) on the development of adjuvant-induced arthritis (AA) in rats","volume":"44","author":"DiMartino","year":"1995","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejmech.2021.113445_bib78","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0040-4039(94)85051-8","article-title":"A\u00a0synthesis of (\u00b1)-hymenin","volume":"35","author":"Xu","year":"1994","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113445_bib79","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1016\/0040-4039(96)01888-6","article-title":"Transbromination of brominated pyrrole and imidazole derivatives: synthesis of the C11N5 marine alkaloid stevensine","volume":"37","author":"Xu","year":"1996","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113445_bib80","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1021\/jo9619746","article-title":"Synthesis of C11N5 marine sponge Alkaloids: (\u00b1)-Hymenin, stevensine, hymenialdisine, and debromohymenialdisine","volume":"62","author":"Xu","year":"1997","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib81","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF01960260","article-title":"\u03b1-Adrenoceptor blocking action of hymenin, a novel marine alkaloid","volume":"44","author":"Kobayashi","year":"1988","journal-title":"Experientia"},{"key":"10.1016\/j.ejmech.2021.113445_bib82","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1021\/jo020063v","article-title":"Synthesis of axinohydantoins","volume":"67","author":"Barrios Sosa","year":"2002","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib83","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.tet.2008.12.053","article-title":"Stereoselective synthesis of (Z)-axino- and (Z)-debromoaxinohydantoin","volume":"65","author":"Tutino","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113445_bib84","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113445_bib85","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(90)90148-8","article-title":"Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis","volume":"63","author":"Cheng","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113445_bib86","doi-asserted-by":"crossref","first-page":"21592","DOI":"10.1016\/S0021-9258(20)80582-1","article-title":"The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells","volume":"268","author":"Lukacs","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib87","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1113\/jphysiol.2009.171595","article-title":"Gating of the CFTR Cl\u2212 channel by ATP-driven nucleotide-binding domain dimerisation","volume":"587","author":"Hwang","year":"2009","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.ejmech.2021.113445_bib88","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","article-title":"Chk1 and Chk2 kinases in checkpoint control and cancer","volume":"3","author":"Bartek","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2021.113445_bib89","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1007\/s00018-013-1307-3","article-title":"Checkpoint kinase 1 in DNA damage response and cell cycle regulation","volume":"70","author":"Patil","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2021.113445_bib90","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/cb200320c","article-title":"Radioprotection by hymenialdisine-derived checkpoint kinase 2 inhibitors","volume":"7","author":"Nguyen","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113445_bib91","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.bmc.2011.12.054","article-title":"Synthesis and evaluation of debromohymenialdisine-derived Chk2 inhibitors","volume":"20","author":"Saleem","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib92","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bmcl.2008.12.001","article-title":"Synthesis and CHK1 inhibitory potency of Hymenialdisine analogues","volume":"19","author":"Parmentier","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113445_bib93","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.tet.2016.03.048","article-title":"Identification of azepinone fused tetracyclic heterocycles as new chemotypes with protein kinase inhibitory activities","volume":"72","author":"Psarra","year":"2016","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113445_bib94","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejmech.2012.08.022","article-title":"Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine","volume":"56","author":"White","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib95","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.tet.2006.11.042","article-title":"Synthesis of latonduine derivatives via intramolecular Heck reaction","volume":"63","author":"Putey","year":"2007","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113445_bib96","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1021\/jm900476c","article-title":"Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure\u2212activity relationship studies","volume":"52","author":"Putey","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib97","doi-asserted-by":"crossref","first-page":"10293","DOI":"10.1016\/j.tet.2012.10.011","article-title":"Palladium-catalyzed intramolecular C\u2013H amidation: synthesis and biological activities of indolobenzazocin-8-ones","volume":"68","author":"Boonya-udtayan","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113445_bib98","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.bmcl.2011.05.052","article-title":"Pyrrolo[2,3-c]azepine derivatives: a new class of potent protein tyrosine phosphatase 1B inhibitors","volume":"21","author":"Xie","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113445_bib99","doi-asserted-by":"crossref","first-page":"103629","DOI":"10.1016\/j.bioorg.2020.103629","article-title":"Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: design, synthesis, biological evaluation and docking studies","volume":"99","author":"Kadagathur","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib100","first-page":"3892","article-title":"Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data","volume":"52","author":"Paull","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2021.113445_bib101","series-title":"Inhibitors of Protein Kinases and Protein Phosphates","first-page":"47","article-title":"The paullones: a family of pharmacological inhibitors of cyclin-dependent kinases and glycogen synthase kinase 3","author":"Meijer","year":"2005"},{"key":"10.1016\/j.ejmech.2021.113445_bib102","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1021\/jm9900570","article-title":"Paullones, a series of cyclin-dependent kinase Inhibitors: synthesis, evaluation of CDK1\/cyclin B inhibition, and in\u00a0vitro antitumor activity","volume":"42","author":"Schultz","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib103","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0960-894X(00)00048-2","article-title":"2-Substituted paullones: CDK1\/cyclin B-inhibiting property and in\u00a0vitro antiproliferative activity","volume":"10","author":"Kunick","year":"2000","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113445_bib104","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1046\/j.1432-1327.2000.01673.x","article-title":"Paullones are potent inhibitors of glycogen synthase kinase-3\u03b2 and cyclin-dependent kinase 5\/p25","volume":"267","author":"Leost","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2021.113445_bib105","first-page":"2566","article-title":"Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases","volume":"59","author":"Zaharevitz","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2021.113445_bib106","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jmb.2003.08.031","article-title":"Structural characterization of the GSK-3\u03b2 active site using selective and non-selective ATP-mimetic inhibitors","volume":"333","author":"Bertrand","year":"2003","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113445_bib107","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3\u03b1 regulates production of Alzheimer\u2019s disease amyloid-\u03b2 peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113445_bib108","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbapap.2003.11.023","article-title":"Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors","volume":"1697","author":"Droucheau","year":"2004","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"key":"10.1016\/j.ejmech.2021.113445_bib109","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2009.10.018","article-title":"Development of 5-benzylpaullones and paullone-9-carboxylic acid alkyl esters as selective inhibitors of mitochondrial malate dehydrogenase (mMDH)","volume":"45","author":"Becker","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj2940625","article-title":"Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B","volume":"294","author":"Welsh","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.113445_bib111","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113445_bib112","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","article-title":"Glycogen synthase kinase-3 from rabbit skeletal muscle","volume":"107","author":"Embi","year":"1980","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2021.113445_bib113","first-page":"485","article-title":"The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction","volume":"354","author":"Cohen","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.ejmech.2021.113445_bib114","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1074\/jbc.M609637200","article-title":"Inhibition of GSK3 promotes replication and survival of pancreatic beta cells","volume":"282","author":"Mussmann","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib115","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1016\/j.bmcl.2010.06.024","article-title":"Concise synthesis and CDK\/GSK inhibitory activity of the missing 9-azapaullones","volume":"20","author":"Power","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113445_bib116","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bmcl.2003.10.062","article-title":"1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3\u03b2","volume":"14","author":"Kunick","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113445_bib117","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1021\/jm701582f","article-title":"9-Cyano-1-azapaullone (Cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic \u03b2 cell protection and replication","volume":"51","author":"Stukenbrock","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib118","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1083\/jcb.200405148","article-title":"The diabetes-linked transcription factor PAX4 promotes \u03b2-cell proliferation and survival in rat and human islets","volume":"167","author":"Brun","year":"2004","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113445_bib119","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1158\/1538-7445.AM2017-2475","article-title":"Abstract 2475: in\u00a0vitro and in\u00a0vivo assessment of the mechanism of action of the PARP inhibitor rucaparib","volume":"77","author":"Robillard","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2021.113445_bib120","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jnci\/djq509","article-title":"Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2, JNCI","volume":"103","author":"Drew","year":"2011","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2021.113445_bib121","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1021\/jm970675l","article-title":"D-fused [1]benzazepines with selective in\u00a0vitro antitumor Activity: synthesis and structure\u2212activity relationships","volume":"41","author":"Link","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib122","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1521-4184(200105)334:5<163::AID-ARDP163>3.0.CO;2-3","article-title":"Aryl rings are part of the darpone pharmacophore","volume":"334","author":"Schultz","year":"2001","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2021.113445_bib123","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1021\/jm2011172","article-title":"Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of polo-like kinase 1 (MLN0905)","volume":"55","author":"Duffey","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib124","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1021\/jm901388c","article-title":"Identification of 2-anilino-9-methoxy-5,7-dihydro-6H-pyrimido[5,4-d][1]benzazepin-6-ones as dual PLK1\/VEGF-R2 kinase inhibitor chemotypes by structure-based lead generation","volume":"53","author":"Egert-Schmidt","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib125","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jhet.5570200330","article-title":"Synthesis of 7-phenylpyrimido[5,4-d][1]benzazepin-2-ones","volume":"20","author":"Chen","year":"1983","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib126","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ddr.20265","article-title":"Integrin alpha(v)beta(3)-targeted cancer therapy","volume":"69","author":"Liu","year":"2008","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2021.113445_bib127","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0968-0896(02)00616-8","article-title":"Design and synthesis of 1,5- and 2,5-substituted tetrahydrobenzazepinones as novel potent and selective integrin \u03b1V\u03b23 antagonists","volume":"11","author":"Kling","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cellimm.2019.02.001","article-title":"Emerging roles of and therapeutic strategies targeting BRD4 in cancer","volume":"337","author":"White","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ejmech.2021.113445_bib129","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026674","article-title":"Targeting cancer cells with BET Bromodomain inhibitors","volume":"7","author":"Xu","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejmech.2021.113445_bib130","article-title":"BET protein-inhibiting 5-aryltriazoleazepines","author":"Schmees","year":"2017"},{"key":"10.1016\/j.ejmech.2021.113445_bib131","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.bmc.2006.02.012","article-title":"Tetrahydropyrrolo[3,2-c]azepin-4-ones as a new class of cytotoxic compounds","volume":"14","author":"Mart\u00ednez","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib132","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bmcl.2005.10.035","article-title":"Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists: quinolin(di)one and benzazepin(di)one derivatives","volume":"16","author":"Geneste","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113445_bib133","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1021\/ic0511120","article-title":"The first metal-based paullone derivative with high antiproliferative activity in\u00a0vitro","volume":"45","author":"Dobrov","year":"2006","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib134","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1021\/jm701042w","article-title":"Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy","volume":"50","author":"Schmid","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113445_bib135","doi-asserted-by":"crossref","first-page":"8559","DOI":"10.1039\/c2cc33786j","article-title":"Ruthenium- and osmium-arene-based paullones bearing a TEMPO free-radical unit as potential anticancer drugs","volume":"48","author":"Arion","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113445_bib136","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jinorgbio.2012.06.003","article-title":"Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cells","volume":"116","author":"M\u00fchlgassner","year":"2012","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2021.113445_bib137","first-page":"2848","article-title":"Synthesis and structure of fluorescent chelate boron complexes of 4-anilinomethylidene-1-benzazepine-2,5-dione ligands","author":"Tolle","year":"2011","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2021.113445_bib138","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1039\/C9DT01238A","article-title":"Novel latonduine derived proligands and their copper(II) complexes show cytotoxicity in the nanomolar range in human colon adenocarcinoma cells and in\u00a0vitro cancer selectivity","volume":"48","author":"Bacher","year":"2019","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2021.113445_bib139","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1634\/theoncologist.2009-0010","article-title":"Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology","volume":"14","author":"Sch\u00f6ffski","year":"2009","journal-title":"The Oncol"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421002944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421002944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:27:30Z","timestamp":1759328850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421002944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":139,"alternative-id":["S0223523421002944"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113445","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fused-azepinones: Emerging scaffolds of medicinal importance","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113445"}}